TerminatedPhase 3NCT00004465
Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Studying Hemolytic uremic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Howard TrachtmanLong Island Jewish Medical Center
- Intervention
- SYNSORB Pk(drug)
- Enrollment
- 145 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 1997 – 2001
Study locations (27)
- Children's Hospital of Denver, Denver, Colorado, United States
- Alfred I. Dupont Institute, Wilmington, Delaware, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- Medical College of Georgia Hospital and Clinics, Augusta, Georgia, United States
- Indiana University Cancer Center, Indianapolis, Indiana, United States
- Boston Floating Hospital Infants and Children, Boston, Massachusetts, United States
- St. Barnabas Medical Center, Livingston, New Jersey, United States
- Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
- Children's Hospital at St. Joseph's, Paterson, New Jersey, United States
- Maimonides Medical Center, Brooklyn, New York, United States
- Children's Hospital of Buffalo, Buffalo, New York, United States
- North Shore University Hospital, Manhasset, New York, United States
- Long Island Jewish Medical Center, New Hyde Park, New York, United States
- Weill Medical College of Cornell University, New York, New York, United States
- University of Rochester Medical Center, Rochester, New York, United States
- +12 more locations on ClinicalTrials.gov
Collaborators
Long Island Jewish Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004465 on ClinicalTrials.govOther trials for Hemolytic uremic syndrome
Additional recruiting or active studies for the same condition.